Inovio Pharmaceuticals Inc
INO
Market Cap$238.38M
Close$
$-1.44
114.2% downside
Current Fair Value
114.2% downsideOvervalued by 114.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $238.38 Million |
|---|---|
| Enterprise Value | $109.85 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-6.09 |
| Beta | 1.28 |
| Outstanding Shares | 23,370,365 |
| Avg 30 Day Volume | 452,756 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.76 |
|---|---|
| PEG | 3.26 |
| Price to Sales | - |
| Price to Book Ratio | 2.03 |
| Enterprise Value to Revenue | 132.04 |
| Enterprise Value to EBIT | -0.83 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
ESG Score
No data
About Inovio Pharmaceuticals Inc
CEO: Jong Kim